SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
The a2 Milk Company Limited (ACOPY) trades at a trailing P/E of 20.7. Trailing earnings yield is 4.84%. PEG 0.95 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (20.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.95); earnings yield beats bond yields (4.84%).
- PEG Ratio 0.95 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.84% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 75/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ACOPY
Valuation Multiples
P/E (TTM)20.7
Forward P/EN/A
PEG Ratio0.95
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.22
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.28
Book Value / Share$0.00
Revenue / Share$2.61
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.84%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.04 |
$352.78M |
$30.44M |
8.6% |
| 2017 |
$0.12 |
$549.53M |
$90.65M |
16.5% |
| 2018 |
$0.26 |
$922.68M |
$195.68M |
21.2% |
| 2019 |
$0.39 |
$1.3B |
$287.74M |
22.1% |
| 2020 |
$0.52 |
$1.73B |
$385.84M |
22.3% |
| 2021 |
$0.11 |
$1.21B |
$80.66M |
6.7% |
| 2022 |
$0.16 |
$1.44B |
$122.62M |
8.5% |
| 2023 |
$0.21 |
$1.59B |
$155.64M |
9.8% |
| 2024 |
$0.23 |
$1.67B |
$167.58M |
10% |
| 2025 |
$0.28 |
$1.9B |
$202.89M |
10.7% |
